##  [Global Lifecycle Management Support Strengthened Portfolio Control for a Biopharma Company](/index%2ephp/success-stories/global-lifecycle-management-support-strengthened-portfolio-control-for-a-biopharma-company) 

# Global Lifecycle Management Support Strengthened Portfolio Control for a Biopharma Company

A biopharma company needed structured lifecycle management support for its pharmaceutical portfolio across various global markets. Freyr delivered comprehensive LCM support aimed at streamlining post-approval processes, ensuring submission continuity, and enhancing regulatory oversight across the entire portfolio.





![]()









![Client Overview]()



![Icon]()  

## Client Overview



The client is a biopharma company managing a pharmaceutical portfolio across global markets. The engagement focused on providing end-to-end lifecycle management support to sustain compliance and portfolio continuity across regions.











![Background Icon]()  

## Background



As portfolio complexity increased across markets, the client needed external support to manage post-approval activities more cohesively. The need centered on maintaining continuity, efficiently handling lifecycle submissions, and supporting global portfolio governance.





![Scope Icon]()  

## Services in Scope



![]()

End-to-end lifecycle management support for a global pharma portfolio.



![]()

Ongoing Regulatory operations to manage post-approval changes and market maintenance activities.



![]()

Portfolio support across multiple international markets.















![Challenge]()



![Challenge]()

## Challenges



![Challenge]()

Complexity of managing lifecycle activities across multiple markets and products.





![Challenge]()

Need to maintain continuity and consistency in global post-approval Regulatory work.





![Challenge]()

Requirement for a scalable support model to handle portfolio-wide LCM demands.















![Challenge]()

## Solution



Freyr provided a centralized LCM support model to coordinate Regulatory maintenance activities across the client’s portfolio. This approach improved visibility, consistency, and operational continuity for post-approval management across global markets.

1

![Challenge]()

Assessed the portfolio’s lifecycle management needs across markets and products.





2

![Challenge]()

Established a structured support model for Regulatory maintenance and post-approval submissions.





3

![Challenge]()

Coordinated portfolio-level activities to improve consistency across markets.





4

![Challenge]()

Supported ongoing lifecycle work to sustain compliance and business continuity.











![Challenge]()

## Impact





![Challenge]()

- Improved management of the client’s pharma portfolio across global markets.





![Challenge]()

- Strengthened continuity of post-approval Regulatory support.





![Challenge]()

- Created a scalable model for ongoing lifecycle management.







This engagement shows how a structured LCM model simplifies post-approval complexity across markets. Freyr’s support helped the client shift from fragmented to coordinated global portfolio management, resulting in better operational control and a more sustainable Regulatory framework.